News
Experimental drug for neuroblastoma shows promise
10 January 2012
Researchers in the US have published the results from their laboratory studies in the journal Science Translational Medicine. They found that a drug called NVP-BEZ235 could prolong survival in mice with the disease. Clinical trials will now be needed to see if this drug is as effective in children with aggressive neuroblastoma.
Professor Andy Pearson, member of CCLG, said "We urgently need better ways to help those children with aggressive neuroblastoma, as this type is very difficult to treat and is a major cause of childhood cancer deaths ... Work like this shows how we're moving away from conventional chemotherapy towards more targeted therapy in neuroblastoma".
Read the full story @ Cancer Research UK
Back to news